Mechanical Thrombectomy in Acute Ischemic Stroke COVID-19 and Non-COVID-19 Patients: A Single Comprehensive Stroke Center Study
- PMID: 36676134
- PMCID: PMC9866657
- DOI: 10.3390/life13010186
Mechanical Thrombectomy in Acute Ischemic Stroke COVID-19 and Non-COVID-19 Patients: A Single Comprehensive Stroke Center Study
Abstract
Coronavirus disease 2019 (COVID-19) increases the risk for thromboembolic events, such as acute ischemic stroke (AIS). Mechanical thrombectomy (MT) is a therapy of choice in early diagnosed AIS; however, its success and outcomes in COVID-19 patients are contradictory. This study presented our experience with MT performed in COVID-19 patients compared to a control group. The retrospective analysis included patients with AIS who underwent MT from April 2021 to April 2022 at our institution. There were 13 COVID-19-related patients (with active or past COVID-19 infection) and 55 non-COVID-19 patients (negative COVID-19 status). We analyzed patients' baseline clinical and laboratory data, modified Thrombolysis in Cerebral Infarction (mTICI) scale, used 24 h follow-up CT findings, and modified the Rankin scale. The COVID-19 group had higher values of leukocytes, neutrophils, neutrophil/leukocyte ratios, ASL, ALT, LDH and CRP, and lower values of lymphocytes compared to the control group. The AIS mostly occurred in posterior circulation in the COVID-19 group, while anterior circulation was more affected in the control group. Treatment approach and successful reperfusion did not differ between groups. In conclusion, although differences in some clinical and laboratory parameters between COVID-19 and non-COVID-19 groups were found, the outcomes of mechanical thrombectomy were equal.
Keywords: COVID-19; acute ischemic stroke; mechanical thrombectomy; neutrophil/lymphocyte ratio.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Follow-up neutrophil-lymphocyte ratio after stroke thrombectomy is an independent biomarker of clinical outcome.J Neurointerv Surg. 2021 Jul;13(7):609-613. doi: 10.1136/neurintsurg-2020-016342. Epub 2020 Aug 6. J Neurointerv Surg. 2021. PMID: 32763917
-
Leukocytes, Collateral Circulation, and Reperfusion in Ischemic Stroke Patients Treated With Mechanical Thrombectomy.Stroke. 2019 Dec;50(12):3456-3464. doi: 10.1161/STROKEAHA.119.026743. Epub 2019 Oct 17. Stroke. 2019. PMID: 31619153
-
Mechanical thrombectomy in COVID-19-associated ischaemic stroke: patient characteristics and outcomes in a single-centre study.Neurol Neurochir Pol. 2022;56(2):163-170. doi: 10.5603/PJNNS.a2022.0026. Epub 2022 Mar 22. Neurol Neurochir Pol. 2022. PMID: 35315928
-
Mechanical Thrombectomy via Transbrachial Approach in the Emergency Management of Acute Ischemic Stroke Patients with Aortic Pathologies: Our Experience and Literature Review.J Pers Med. 2024 Feb 18;14(2):216. doi: 10.3390/jpm14020216. J Pers Med. 2024. PMID: 38392649 Free PMC article. Review.
-
Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested Knowledge.Front Neurol. 2021 Dec 17;12:759759. doi: 10.3389/fneur.2021.759759. eCollection 2021. Front Neurol. 2021. PMID: 34975722 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous